Bienville Capital Management LLC Buys Shares of 989,013 Oscar Health, Inc. $OSCR

by · The Markets Daily

Bienville Capital Management LLC purchased a new stake in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 989,013 shares of the company’s stock, valued at approximately $21,204,000. Oscar Health comprises about 4.2% of Bienville Capital Management LLC’s portfolio, making the stock its 8th biggest holding. Bienville Capital Management LLC owned about 0.39% of Oscar Health as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the stock. Hsbc Holdings PLC lifted its position in Oscar Health by 2.7% during the first quarter. Hsbc Holdings PLC now owns 24,113 shares of the company’s stock valued at $313,000 after purchasing an additional 632 shares during the period. Wealthspire Advisors LLC raised its stake in Oscar Health by 6.7% during the 2nd quarter. Wealthspire Advisors LLC now owns 11,117 shares of the company’s stock valued at $238,000 after buying an additional 700 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in Oscar Health by 14.4% during the 2nd quarter. PNC Financial Services Group Inc. now owns 7,140 shares of the company’s stock valued at $153,000 after buying an additional 900 shares during the last quarter. Focus Partners Wealth lifted its holdings in shares of Oscar Health by 1.8% during the 1st quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock valued at $723,000 after buying an additional 949 shares during the period. Finally, LRI Investments LLC boosted its stake in shares of Oscar Health by 377.9% in the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after buying an additional 975 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Insider Activity

In other Oscar Health news, CFO Richard Scott Blackley sold 25,135 shares of the stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $416,989.65. Following the completion of the sale, the chief financial officer owned 1,351,034 shares in the company, valued at approximately $22,413,654.06. This represents a 1.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Janet Liang sold 7,338 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $121,737.42. Following the completion of the transaction, the insider owned 172,527 shares in the company, valued at $2,862,222.93. The trade was a 4.08% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 739,472 shares of company stock worth $12,616,880. 24.39% of the stock is currently owned by corporate insiders.

Oscar Health Trading Up 4.6%

Oscar Health stock opened at $16.60 on Friday. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.80. The firm has a market capitalization of $4.39 billion, a price-to-earnings ratio of -14.82 and a beta of 1.88. The firm has a 50 day moving average of $17.70 and a 200 day moving average of $16.99. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR – Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. The business had revenue of $2.93 billion during the quarter, compared to analyst estimates of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The company’s revenue was up 23.2% on a year-over-year basis. During the same period in the prior year, the business posted ($0.22) earnings per share. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Barclays upped their price objective on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a research report on Monday, November 10th. Wells Fargo & Company reduced their price target on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research report on Thursday, November 13th. Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $13.00 to $25.00 in a report on Tuesday, November 25th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a research report on Wednesday, October 8th. Finally, Stephens began coverage on shares of Oscar Health in a report on Thursday. They set an “equal weight” rating and a $17.00 target price for the company. One investment analyst has rated the stock with a Buy rating, six have assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $15.57.

View Our Latest Research Report on Oscar Health

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading